Leonurine Ameliorates Doxorubicin‐Induced Cardiotoxicity via STING/NF‐κB/NLRP3 Inflammasome Signaling Pathway
Advanced Science · 2026
DOI: 10.1002/advs.75912 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Wang Jun und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Doxorubicin, NLR Family, Pyrin Domain-Containing 3 Protein, Cardiotoxicity, Gallic Acid. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Doxorubicin‐induced cardiomyopathy (DIC) remains a dose‐limiting clinical challenge. This study reveals that cardiac vascular endothelial cells (CVECs) act as initial sensors of doxorubicin cardiotoxicity: circulating doxorubicin activates the cGAS‑STING pathway in CVECs, triggering NLRP3 inflammasome‑mediated pyroptosis and release of pathogenic extracellular vesicles that induce mitochondrial dysfunction in neighboring cardiomyocytes, establishing a self‑perpetuating injury loop. Leonurine (LEO), a natural alkaloid, is identified as a direct STING inhibitor that specifically binds the TYR261 residue, blocking both STING oligomerization and STING‑TBK1 heterodimer formation—a mechanism distinct from known STING inhibitors. LEO exerts hierarchical dual protection: directly preserving cardiomyocyte mitochondria while primarily inhibiting endothelial STING to disrupt the pathogenic loop. This endothelial‑centric strategy shifts the therapeutic paradigm from direct cardiomyocyte protection to upstream endothelial intervention, establishing LEO as a promising candidate for DIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Institute of Formula and Syndrome, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Chinese Medicine Guangdong Laboratory, Hengqin, China.
- Science and Technology Innovation Center, Zhengzhou Hospital of Traditional Chinese Medicine (Zhengzhou Hospital of TCM Affiliated to Henan University of Chinese Medicine), Zhengzhou, China.
- Henan Provincial Key Laboratory of Traditional Chinese Medicine for Cardiovascular Diseases, Zhengzhou Hospital of Traditional Chinese Medicine, Zhengzhou, China.
ORCID-Profile: Xu Jianglin, Xu Xuegong
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- National Science Fund for Excellent Young Scholars
- Youth Science Fund Project
Zitieren
APA
Jun, W., Xiaoyang, C., Jianglin, X., Zhi, Y., Meijiao, T., Jiale, H., Jiangfeng, Z., Xuanding, H., Xuegong, X., Wei, W., & Chun, L. (2026). Leonurine Ameliorates Doxorubicin‐Induced Cardiotoxicity via STING/NF‐κB/NLRP3 Inflammasome Signaling Pathway. Advanced Science. https://doi.org/10.1002/advs.75912
Vancouver
Jun W, Xiaoyang C, Jianglin X, Zhi Y, Meijiao T, Jiale H, et al. Leonurine Ameliorates Doxorubicin‐Induced Cardiotoxicity via STING/NF‐κB/NLRP3 Inflammasome Signaling Pathway. Advanced Science. 2026. doi:10.1002/advs.75912
BibTeX
@article{Jun2026,
author = {Jun, Wang and Xiaoyang, Chen and Jianglin, Xu and Zhi, Yang and Meijiao, Tao and Jiale, He and Jiangfeng, Zhao and Xuanding, Hei and Xuegong, Xu and Wei, Wang and Chun, Li},
title = {Leonurine Ameliorates Doxorubicin‐Induced Cardiotoxicity via STING/NF‐κB/NLRP3 Inflammasome Signaling Pathway},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.75912}
}
EUVIMED